Innovation: Peds: MOMS

Myelomeningocele Trial (MOMS)

Primary investigator of the NIH-funded Myelomeningocele Trial (MOMS) 1 and 2

Our doctors are pioneers in fetal intervention for myelomeningocele. Drs. Tulipan and Bruner completed the first human interventions in 1998.  Dr. John Brock, III helped create the protocol that became the MOMS Trial, the only randomized trial comparing pre- and post-natal myelomeningocele closure in the world. This trial included three institutions, including Vanderbilt. Outcomes of this trial are summarized in the papers below, all of which include authors from our division.

Selected Publications